Two Sigma Securities’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-400
| Closed | -$309K | – | 1878 |
|
|
2024
Q4 | $309K | Sell |
400
-15,800
| -98% | -$13.1M | 0.04% | 626 |
|
|
2024
Q3 | $14.4M | Sell |
16,200
-1,900
| -10% | -$1.71M | 0.24% | 89 |
|
|
2024
Q2 | $16.4M | Sell |
18,100
-16,000
| -47% | -$12.8M | 0.2% | 102 |
|
|
2024
Q1 | $26.5M | Sell |
34,100
-32,500
| -49% | -$23.1M | 0.26% | 87 |
|
|
2023
Q4 | $38.8M | Buy |
66,600
+24,400
| +58% | +$14.2M | 0.38% | 37 |
|
|
2023
Q3 | $22.7M | Sell |
42,200
-12,000
| -22% | -$6.18M | 0.24% | 78 |
|
|
2023
Q2 | $25.4M | Buy |
54,200
+21,900
| +68% | +$9.18M | 0.38% | 42 |
|
|
2023
Q1 | $11.1M | Buy |
32,300
+19,000
| +143% | +$6.41M | 0.22% | 86 |
|
|
2022
Q4 | $4.87M | Buy |
13,300
+9,200
| +224% | +$3.26M | 0.15% | 153 |
|
|
2022
Q3 | $1.33M | Buy |
4,100
+100
| +3% | +$31.7K | 0.04% | 510 |
|
|
2022
Q2 | $1.3M | Buy |
4,000
+3,000
| +300% | +$901K | 0.05% | 430 |
|
|
2022
Q1 | $286K | Buy |
+1,000
| New | +$257K | 0.01% | 1438 |
|
|
2021
Q4 | – | Sell |
-6,900
| Closed | -$1.59M | – | 1818 |
|
|
2021
Q3 | $1.59M | Sell |
6,900
-3,600
| -34% | -$889K | 0.05% | 353 |
|
|
2021
Q2 | $2.41M | Buy |
+10,500
| New | +$2.11M | 0.07% | 203 |
|
|
2021
Q1 | – | Sell |
-16,800
| Closed | -$2.84M | – | 1352 |
|
|
2020
Q4 | $2.84M | Buy |
16,800
+12,200
| +265% | +$1.82M | 0.07% | 189 |
|
|
2020
Q3 | $681K | Sell |
4,600
-12,300
| -73% | -$1.9M | 0.01% | 480 |
|
|
2020
Q2 | $2.77M | Sell |
16,900
-36,700
| -68% | -$5.63M | 0.06% | 170 |
|
|
2020
Q1 | $7.43M | Sell |
53,600
-87,100
| -62% | -$12M | 0.17% | 72 |
|
|
2019
Q4 | $18.5M | Sell |
140,700
-35,200
| -20% | -$4.08M | 0.12% | 113 |
|
|
2019
Q3 | $19.7M | Buy |
175,900
+96,100
| +120% | +$10.7M | 0.18% | 69 |
|
|
2019
Q2 | $8.84M | Buy |
79,800
+28,900
| +57% | +$3.4M | 0.09% | 132 |
|
|
2019
Q1 | $6.61M | Sell |
50,900
-5,600
| -10% | -$681K | 0.06% | 139 |
|
|
2018
Q4 | $6.54M | Sell |
56,500
-38,900
| -41% | -$4.35M | 0.08% | 131 |
|
|
2018
Q3 | $10.2M | Sell |
95,400
-103,500
| -52% | -$10.3M | 0.07% | 207 |
|
|
2018
Q2 | $17M | Buy |
198,900
+9,800
| +5% | +$805K | 0.08% | 172 |
|
|
2018
Q1 | $14.6M | Buy |
189,100
+163,500
| +639% | +$13.2M | 0.08% | 210 |
|
|
2017
Q4 | $2.16M | Buy |
+25,600
| New | +$2.18M | 0.06% | 250 |
|
Other funds holding LLY
VCM
VPM
Two Sigma Securities's LLY Position: Q1 2026 in Review
Two Sigma Securities sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,877 shares — an estimated $2.02M sold.
Two Sigma Securities first reported a position in LLY in Q3 2016 and held it in 23 quarters. The position peaked at $59.2M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Two Sigma Securities reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
- Two Sigma Securities sold 1,877 Eli Lilly shares in Q1 2026, an estimated $2.02M.
- Two Sigma Securities first reported a position in Eli Lilly in Q3 2016 and held it in 23 quarters.
- Two Sigma Securities's Eli Lilly position peaked at $59.2M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.